Drug for Irritable Bowel Syndrome, Withdrawn.
Minneapolis, St. Paul Pharmaceutical Drug Injury Lawyers, Lord & Faris Can Help you Evaluate Your Zelnorm Claim:
Contact Lord & Faris for a free evaluation of your claim. 1-866-250-1786, local 612-333-LORD.
The FDA Stops The Marketing Of Zelnorm:
The FDA announced that Novartis Pharmaceuticals has agreed to stop marketing Zelnorm (tegaserod), used to treat irritable bowel syndrome, after a recent safety analysis found an increased risk for serious cardiovascular events.
Zelnorm was approved for short-term treatment of women with irritable bowel syndrome whose primary symptom is constipation and for men and women younger than 65 with chronic constipation.
An analysis of 29 placebo-controlled clinical trials comprising over 18,000 patients conducted by Novartis found 0.1% of patients taking Zelnorm showed evidence of a serious cardiovascular event, compared with 0.01% taking a placebo. The FDA concluded that, for most patients, the benefits of Zelnorm no longer outweigh the risks. The agency is working with the manufacturer to keep the drug available for those who have no other treatment options.
Were you injured by a defective drug or supplement? If so, please save the product and instructions for the product. Also, if you have the box the product came in that would be helpful. All of this information may be vital to proving your case.
Contact us for a free evaluation of your claim. 1-866-250-1786, local 651-641-1500.
Our Minneapolis Personal Injury Attorneys are experienced in resolving and litigating issues resulting from a wide variety of injuries, including: